Literature DB >> 1585769

Marked decline of favism after neonatal glucose-6-phosphate dehydrogenase screening and health education: the northern Sardinian experience.

T Meloni1, G Forteleoni, G F Meloni.   

Abstract

Favism is a potentially fatal manifestation of glucose-6-phosphate dehydrogenase (G6PD) deficiency, and it is therefore a public health problem in areas where this genetic abnormality is common. In the district of Sassari (northern Sardinia), the frequency of G6PD male hemizygotes is approximately 7.5%, and therefore all newborns since 1971 have been screened for G6PD deficiency. We have analyzed the incidence of favism in this community in two 10-year periods: (1) 1961-1970; and (2) 1981-1990. In period 1, there were 508 cases of favism, of which 76% occurred in boys. In period (2) there were 144 cases of favism, of which only 52% in boys. Thus, between the two periods there was an overall decrease in the incidence of favism of 75%, whereas the proportion of girls affected has approximately doubled. These data suggest that neonatal screening and health education programs can produce a substantial decrease in the number of cases of favism, and that the relative increase in favism in girls is possibly due to failure of the screening method used to detect all the heterozygotes for G6PD deficiency.

Entities:  

Mesh:

Year:  1992        PMID: 1585769     DOI: 10.1159/000204709

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  8 in total

Review 1.  Parental education and the WHO neonatal G-6-PD screening program: a quarter century later.

Authors:  M Kaplan; C Hammerman; V K Bhutani
Journal:  J Perinatol       Date:  2015-07-16       Impact factor: 2.521

Review 2.  Glucose-6-phosphate dehydrogenase deficiency.

Authors:  A B Mehta
Journal:  Postgrad Med J       Date:  1994-12       Impact factor: 2.401

3.  Pediatric Provider Insight Into Newborn Screening for Glucose-6-Phosphate Dehydrogenase Deficiency.

Authors:  Janine Bernardo; Mary Nock
Journal:  Clin Pediatr (Phila)       Date:  2014-11-10       Impact factor: 1.168

4.  High incidence of glucose-6-phosphate dehydrogenase deficiency in Croatian island isolate: example from Vis island, Croatia.

Authors:  Josko Markić; Vjekoslav Krzelj; Anita Markotić; Eugenija Marusić; Luka Stricević; Jaksa Zanchi; Nada Bosnjak; Ada Sapunar
Journal:  Croat Med J       Date:  2006-08       Impact factor: 1.351

5.  Glucose-6-phosphate dehydrogenase variants associated with favism in Thai children.

Authors:  Vichai Laosombat; Benjamas Sattayasevana; Teerachit Chotsampancharoen; Malai Wongchanchailert
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

6.  Glucose-6-phosphate dehydrogenase deficiency among malaria suspects attending Gambella hospital, southwest Ethiopia.

Authors:  Arega Tsegaye; Lemu Golassa; Hassen Mamo; Berhanu Erko
Journal:  Malar J       Date:  2014-11-18       Impact factor: 2.979

Review 7.  Point-of-Care Testing for G6PD Deficiency: Opportunities for Screening.

Authors:  Athena Anderle; Germana Bancone; Gonzalo J Domingo; Emily Gerth-Guyette; Sampa Pal; Ari W Satyagraha
Journal:  Int J Neonatal Screen       Date:  2018-11-19

Review 8.  Optimizing G6PD testing for Plasmodium vivax case management and beyond: why sex, counseling, and community engagement matter.

Authors:  Cindy S Chu; Germana Bancone; Maureen Kelley; Nicole Advani; Gonzalo J Domingo; Eva M Cutiongo-de la Paz; Nicole van der Merwe; Jessica Cohen; Emily Gerth-Guyette
Journal:  Wellcome Open Res       Date:  2020-08-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.